New Therapeutic Strategy and Innovative Lubricating Ophthalmic Solution in Minimizing Dry Eye Disease Associated with Cataract Surgery: A Randomized, Prospective Study

ConclusionsThe ocular surface was more protected and quickly restored from surgery when VisuEvo® was used from 2  weeks preoperatively to 2 weeks postoperatively.Trial registrationClinicalTrials.gov identifier, NCT03833908

Source: Advances in Therapy - March 16, 2020 Category: Drugs & Pharmacology Source Type: research